| Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer SA Miraghel, N Ebrahimi, L Khani, A Mansouri, A Jafarzadeh, A Ahmadi, ... Pharmacological Research 176, 106041, 2022 | 25 | 2022 |
| Role of myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target E Nourbakhsh, A Mohammadi, M Salemizadeh Parizi, A Mansouri, ... Inflammopharmacology 29, 1307-1315, 2021 | 18 | 2021 |
| The potential application of organoids in breast cancer research and treatment N Ebrahimi, A Nasr Esfahani, S Samizade, A Mansouri, M Ghanaatian, ... Human genetics, 1-16, 2022 | 16 | 2022 |
| Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy N Ebrahimi, AHRR Abdulwahid, A Mansouri, N Karimi, RJ Bostani, ... Cellular and Molecular Life Sciences 81 (1), 106, 2024 | 15 | 2024 |
| Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers N Ebrahimi, A Hakimzadeh, F Bozorgmand, S Speed, MS Manavi, ... Cell Cycle 22 (20), 2302-2323, 2023 | 3 | 2023 |
| Identification of hub genes and pathways in hepatitis B virus‐associated hepatocellular carcinoma: A comprehensive in silico study NS Kalaki, M Ahmadzadeh, A Mansouri, M Saberiyan, MH Karbalaie Niya Health Science Reports 7 (6), e2185, 2024 | | 2024 |
